European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

Registry of Pregnancy and Cardiac disease (ROPAC)

Learn about the EORP Registry of Pregnancy and Cardiac disease

 See our Publications!

We are pleased to inform you that our manuscript entitled Outcome of pregnancy in patients with structural or ischemic heart disease: results of a registry of the European Society of Cardiology has been published in the European Heart Journal.
Read the abstract of the article.

This publication is cited in the editorial article of European Heart journal The ROPAC registry: a multicentre collaboration on pregnancy outcomes in women with heart disease.
Read the abstract of the editorial.

The article entitled Heart failure in pregnant women with cardiac disease: data from the ROPAC has been published by Heart.
Read the abstract of the article

Objectives and characteristics of the study

 

The impact of pregnancy on women with heart disease or the impact of maternal disease on the outcome of pregnancy for the baby is not yet fully understood. Pregnant women may have a spectrum of structural heart disease including congenital heart disease, rheumatic heart disease, pulmonary hypertension, cardiomyopathy, aortic disease and coronary artery disease. The heterogeneous nature of this group means that the information we use currently to develop our management protocols is incomplete and fragmented. The information provided by this registry will enable us to improve the accuracy of advice to women both before and during pregnancy and to develop better management protocols. It may also allow randomized studies to be targeted at specific problems. Such a registry has to be large in order to collect information on a sufficient numbers of patients with the wide variety of possible situations which may occur. 

 

Objectives

  • Determine the variation over the participating countries of structural heart disease for pregnant patients in the participating countries:
    • Type of heart disease (i.e. valvular, congenital, ischaemic, cardiomyopathy)
    • Age during pregnancy
    • Medication used before/during pregnancy
    • Mode of delivery
  • Assess the maternal and foetal mortality and morbidity during pregnany and 6 months after pregnancy
  • Document the incidence of congenital heart disease in the babies born from women with congenital heart disease
  • Assess prospectively the changes in maternal cardiac function as a consequence of pregnancy using echocardiography
  • Assess use of medical resources utilisation (caesarean section, epidural anaesthesia) and its impact on outcome in different countries
  • Assess the results and complication rate of interventions performed during pregnancy
  • Test the value of the existing risk models on pregnancy outcome in patients with heart disease
  • Compare different types of anticoagulant therapy strategies used during pregnancy

Characteristics

Centres from over 30 nations, such as several European countries, USA, Canada, Brazil, South Africa, Japan... have already been participating in this project in the past.

Today 47 countries and 125 centres are participating in the registry, and we expect more to join.

If you are already registered as a participant in EORP programme, you may connect to our secure website: http://www.eorp.org

Study Organisation

The Executive Committee of the registry is chaired by Professor Roger Hall (UK) and Professor Jolien Roos-Hesselink (NL) on behalf of the ESC and EORP.

  

If you wish to know more about this registry please click on the button.

Back to EORP introduction